Fusion Pharmaceuticals (NASDAQ:FUSN) Sets New 52-Week High at $12.79 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Fusion Pharmaceuticals (NASDAQ:FUSN) Hits New 1-Year High at $12.79 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Free Report) – Analysts at Leerink Partnrs issued their Q1 2024 earnings per share (EPS) estimates for Fusion Pharmaceuticals in a note issued to investors on Monday, January 29th. Leerink Partnrs analyst F. Khurshid expects that the company will post earnings per share of ($0.32) for the quarter. The consensus […]
Shares of Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report) gapped down before the market opened on Monday . The stock had previously closed at $9.12, but opened at $8.75. Fusion Pharmaceuticals shares last traded at $9.25, with a volume of 63,888 shares traded. Wall Street Analyst Weigh In FUSN has been the subject of […]
Fusion Pharmaceuticals (NASDAQ:FUSN – Get Free Report)‘s stock had its “outperform” rating reissued by stock analysts at William Blair in a research report issued on Friday, RTT News reports. Other analysts have also recently issued research reports about the company. Royal Bank of Canada started coverage on Fusion Pharmaceuticals in a research report on Wednesday, […]